3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine>98.0%(GC)25g

O-Acetyl-L-serine, 95.0%, 100mg

Ethyl 2-(1H-1,2,3-benzotriazol-1-yl)hexanoate, 70.0%, 100mg

2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile, 95.0%, 100mg

Zernike phase contrast kit with E-Plan phase EPLPHi 10/20/S40/S100 oil immersion IOS objectives, rotating Zernike condenser, telescope and green filter

7-Bromo-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one, 97%, 50mg

1-Phenyl-3-(phenylamino)pyrrolidine-2,5-dione, 98%, 100mg

NN-Dimethylbutyramide, Pract., 98%, 1g

1-(2,4-Dihydroxy-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)-3-(4-hydroxyphenyl)propan-1-one dihydrate, 98+%, 10g

O-ALLYLHYDROXYLAMINE HCL, 97.0%, 10g

(2R,3S)-3-hydroxynorvaline hydrochloride, 50mg

1,4,7,10,13-Pentaoxa-16-azacyclooctadecane, 95.0%, 100mg

N-Methyl-L-valine hydrochloride, 95.0%, 1g